Co-Enzyme Q10 and Statins


A lawsuit filed in Washington, D.C. requested that the FDA require labeling on statin drugs stating that they can decrease Co-Q10 levels in patients taking the drug. Canada requires statin labeling to carry a label warning regarding increased risks of Co-Q10 loss.

Return to Newsletter Archive

Disclaimer: The statements and information upon this website have not necessarily been evaluated by the Food and Drug Administration. The products featured are not intended to diagnose, treat, cure or prevent any disease. Consumers should always consult their own medical practitioner(s) with any medical or health concerns before starting any new diet, product or supplement.